CorMedix Inc. logo CRMD - CorMedix Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.00 DETAILS
HIGH: $16.00
LOW: $13.00
MEDIAN: $13.50
CONSENSUS: $14.00
UPSIDE: 75.44%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue
Revenue 311.7 43.5 0 0.1 0.2 0.2 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0 0 0 0 0
Cost of Revenue 36.0 3.2 0.2 0.0 0.1 0.2 0.4 0.4 0.1 0.4 0.3 0.4 0.2 0 0 0 0 1.0
Gross Profit 275.7 40.3 (0.2) 0.1 0.0 0.0 (0.1) 0.0 0.2 (0.1) (0.1) (0.3) (0.2) 0 0 0 0 (1.0)
Operating Expenses
R&D Expenses 19.3 3.9 13.2 10.7 13.1 13.4 11.1 18.8 24.5 15.7 6.3 1.3 1.2 1.2 4.1 5.5 4.9 3.1
SG&A Expenses 30.2 58.7 35.8 20.0 16.3 13.9 0 8.1 8.7 8.9 10.3 7.3 3.5 1.9 3.1 3.0 1.2 0.7
Other Expenses 76.1 0 0 0 0 0 9.9 0 0 0 0 0 (0.0) 0 0 0 0 0
Operating Expenses 125.6 62.6 48.8 30.7 29.5 27.3 20.9 26.9 33.1 24.6 16.5 8.6 4.7 3.0 7.2 8.5 6.1 3.8
Operating Income
Operating Income 150.1 (22.4) (49.0) (30.6) (29.4) (27.2) (21.0) (26.9) (32.9) (24.8) (16.7) (8.9) (4.9) (3.0) (7.2) (8.5) (6.1) (4.8)
Interest Expense 2.8 0.0 0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 3.1 2.1 4.2
Interest Income 3.8 2.6 2.7 0.3 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Profitability
EBITDA 165.1 (19.0) (46.2) (30.1) (29.4) (27.0) (20.9) (26.8) (33.0) (24.6) (18.2) (20.4) (7.7) (3.0) (7.2) (8.5) (6.0) (3.7)
EBIT 150.1 (19.3) (46.3) (30.3) (29.4) (27.2) (21.0) (26.8) (33.0) (24.6) (18.2) (20.5) (7.7) (3.0) (7.2) (8.1) (6.1) (4.8)
Income Before Tax 150.0 (19.3) (46.3) (30.3) (29.5) (27.2) (11.4) (26.8) (33.0) (24.6) (18.2) (20.5) (9.1) (3.4) (7.2) (11.2) (8.1) (9.0)
Income Tax Expense (13.0) (1.4) 0 (0.6) (1.3) (5.2) 5.1 0.0 (0.0) 0.0 0.0 0.0 0 0.0 (0.5) (0.3) 0.0 0
Net Income 163.1 (17.9) (46.3) (29.7) (28.2) (22.0) (16.4) (26.8) (33.0) (24.6) (18.2) (20.5) (9.1) (3.4) (6.7) (10.9) (8.1) (9.0)
Per Share Data
EPS (Basic) 2.25 -0.30 -0.91 -0.74 -0.75 -0.77 -0.68 -1.51 -2.99 -3.25 -2.90 -4.77 -3.30 -1.50 -2.94 -5.76 -47.40 -53.42
EPS (Diluted) 2.04 -0.30 -0.91 -0.74 -0.75 -0.77 -0.68 -1.51 -2.99 -3.25 -2.90 -4.77 -3.30 -1.50 -2.94 -5.76 -47.40 -53.42
Shares Outstanding 72.0 58.9 50.9 40.1 37.6 28.6 24.2 17.8 11.0 7.6 6.3 4.3 2.8 2.3 2.3 1.9 0.2 0.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 145.8 40.7 43.6 43.4 53.3 41.9 16.5 17.6 10.4 8.1 1.5 1.4
Short-Term Investments 3.7 11.0 32.4 15.6 12.1 4.4 12.0 0 1.6 12.1 0 0
Net Receivables 171.2 51.7 0 0 0.0 0.0 0 0.0 0.1 0.0 0 0
Inventory 29.7 7.6 2.1 0 0.0 0.1 0.3 0.4 0.6 0.2 0 0
Other Current Assets 8.5 3.5 1.0 (0.1) 0.9 0.3 0.1 0.2 0.3 1.1 0 0.0
Total Current Assets 367.1 114.6 79.5 59.6 66.5 48.2 29.3 18.7 13.3 21.8 1.7 1.4
Non-Current Assets
Property, Plant & Equipment 9.9 2.3 2.5 2.4 2.4 1.1 0.1 0.2 0.2 0.1 0.0 0.0
Goodwill 30.0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 379.1 1.8 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 10.4 0 0 0 0 0 0 0 0 0 0.0 0
Other Non-Current Assets 14.4 0.1 0.1 0.1 0.1 0 0 0 0 0.0 0.5 0.2
Total Non-Current Assets 459.1 4.3 2.6 2.5 2.5 1.1 0.1 0.2 0.2 0.1 0.5 0.2
Total Assets 826.1 118.8 82.1 62.0 68.9 49.3 29.5 18.8 13.5 21.9 2.2 1.6
Current Liabilities
Account Payables 7.9 1.7 4.3 2.2 2.2 1.1 1.0 2.6 1.8 1.6 0.5 0.8
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 13.8 11.7
Deferred Revenue 0 0 0 0 0 0 0.0 0.0 0.1 0.1 0 0
Other Current Liabilities 5.3 0 0 0 0 0 3.5 4.1 3.6 0 0 1.2
Total Current Liabilities 174.3 33.8 11.4 6.3 5.3 4.2 5.8 7.8 6.3 4.1 16.9 13.6
Non-Current Liabilities
Long-Term Debt 144.6 0 0 0 0 0 0 6.1 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 99.1 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 246.6 0.3 0.5 0.7 0.8 0.9 0.0 6.1 0 0 0 0
Total Liabilities 420.8 34.2 11.9 7.0 6.1 5.1 5.8 13.9 6.3 4.1 16.9 13.6
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0
Retained Earnings (176.6) (339.6) (321.7) (275.4) (245.7) (217.4) (195.4) (179.0) (152.2) (119.2) (25.3) (17.2)
Accumulated Other Comprehensive Income 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 (0.0) (0.0)
Total Stockholders' Equity 405.3 84.7 70.1 55.1 62.8 44.2 (195.4) (179.0) (152.2) 17.8 (14.7) (12.0)
Total Liabilities & Equity 826.1 118.8 82.1 62.0 68.9 49.3 (189.6) (165.1) (145.9) 21.9 2.2 1.6
Debt Metrics
Total Debt 148.9 0.5 0.7 0.8 0.9 1.0 0.0 6.1 0 0 13.8 11.7
Net Debt 3.1 (40.1) (43.0) (42.6) (52.4) (40.9) (16.5) (11.5) (10.4) (8.1) 12.3 10.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 163.1 (17.9) (46.3) (29.7) (28.2) (22.0) (16.4) (26.8) (33.0) (24.6)
Depreciation & Amortization 0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 0 6.1 5.5 4.1 5.0 2.5 2.4 1.1 1.7 1.3
Change in Working Capital 7.3 (39.4) 2.2 1.1 1.8 (2.6) (1.9) 1.9 2.9 0.9
Other Non-Cash Items 4.7 0.3 0.1 0.1 0.1 0.1 1.4 3.1 4.4 0.1
Operating Cash Flow 175.0 (50.6) (38.4) (24.4) (21.2) (22.0) (15.1) (23.7) (28.6) (22.3)
Investing Activities
Capital Expenditure (2.3) (0.1) (0.3) (0.2) (1.4) (0.1) (0.0) (0.0) (0.2) (0.1)
Acquisitions (308.5) 0 0 0 0 0 12.0 0 0 0
Purchases of Investments (53.0) (26.8) (77.1) (31.1) (15.3) (8.5) (14.1) 0 (13.1) 0
Sales/Maturities of Investments 55.3 48.1 60.4 27.6 7.6 16.1 2.1 1.6 23.6 11.5
Other Investing Activities 0 0 0 0 0 0 (12.0) 1.6 10.5 11.5
Investing Cash Flow (308.4) 21.2 (17.1) (3.7) (9.1) 7.4 (12.0) 1.6 10.4 11.4
Financing Activities
Net Debt Issuance 144.1 0 0 0 0 0 0 7.5 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (2.2) 7.4 0.1 0.1 0.3 0.4 10.6 (0.1) 0.0 0.9
Financing Cash Flow 238.5 26.3 55.9 17.9 41.8 40.1 25.8 29.4 20.5 7.1
Cash Position
Net Change in Cash 105.1 (3.1) 0.4 (10.2) 11.5 25.6 (1.3) 7.2 2.3 (3.8)
Cash at Beginning 40.8 43.8 43.4 53.6 42.1 16.5 17.8 10.4 8.1 11.8
Cash at End 145.8 40.8 43.8 43.4 53.6 42.1 16.5 17.6 10.4 8.1
Free Cash Flow 172.8 (50.7) (38.7) (24.6) (22.6) (22.1) (15.1) (23.7) (28.7) (22.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Income Statement
Revenue 311.7 43.5 0 0.1 0.2 0.2 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0 0 0 0 0
Gross Profit 275.7 40.3 (0.2) 0.1 0.0 0.0 (0.1) 0.0 0.2 (0.1) (0.1) (0.3) (0.2) 0 0 0 0 (1.0)
Operating Income 150.1 (22.4) (49.0) (30.6) (29.4) (27.2) (21.0) (26.9) (32.9) (24.8) (16.7) (8.9) (4.9) (3.0) (7.2) (8.5) (6.1) (4.8)
Net Income 163.1 (17.9) (46.3) (29.7) (28.2) (22.0) (16.4) (26.8) (33.0) (24.6) (18.2) (20.5) (9.1) (3.4) (6.7) (10.9) (8.1) (9.0)
EPS (Diluted) 2.04 -0.30 -0.91 -0.74 -0.75 -0.77 -0.68 -1.51 -2.99 -3.25 -2.90 -4.77 -3.30 -1.50 -2.94 -5.76 -47.40 -53.42
Balance Sheet
Cash & Equivalents 145.8 40.7 43.6 43.4 53.3 41.9 16.5 17.6 10.4 8.1 1.5 1.4
Total Assets 826.1 118.8 82.1 62.0 68.9 49.3 29.5 18.8 13.5 21.9 2.2 1.6
Total Debt 148.9 0.5 0.7 0.8 0.9 1.0 0.0 6.1 0 0 13.8 11.7
Stockholders' Equity 405.3 84.7 70.1 55.1 62.8 44.2 (195.4) (179.0) (152.2) 17.8 (14.7) (12.0)
Cash Flow
Operating Cash Flow 175.0 (50.6) (38.4) (24.4) (21.2) (22.0) (15.1) (23.7) (28.6) (22.3)
Capital Expenditure (2.3) (0.1) (0.3) (0.2) (1.4) (0.1) (0.0) (0.0) (0.2) (0.1)
Free Cash Flow 172.8 (50.7) (38.7) (24.6) (22.6) (22.1) (15.1) (23.7) (28.7) (22.3)